tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Altimmune rallies after FDA accepts liver stiffness as MASH endpoint
PremiumThe FlyAltimmune rallies after FDA accepts liver stiffness as MASH endpoint
30d ago
Altimmune announces FDA Fast Track designation for pemvidutide
Premium
The Fly
Altimmune announces FDA Fast Track designation for pemvidutide
1M ago
Altimmune price target lowered to $24 from $26 at UBS
Premium
The Fly
Altimmune price target lowered to $24 from $26 at UBS
1M ago
Options Volatility and Implied Earnings Moves Today, August 12, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, August 12, 2025
2M ago
Altimmune board of directors appoint Jerry Durso as Chairman
Premium
The Fly
Altimmune board of directors appoint Jerry Durso as Chairman
2M ago
Options Volatility and Implied Earnings Moves This Week, August 11 – August 14, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, August 11 – August 14, 2025
2M ago
Altimmune price target lowered to $15 from $25 at Citizens JMP
PremiumThe FlyAltimmune price target lowered to $15 from $25 at Citizens JMP
3M ago
Altimmune resumed with a Sell at Goldman Sachs
Premium
The Fly
Altimmune resumed with a Sell at Goldman Sachs
3M ago
Sell Rating for Altimmune Inc. Due to Financial Struggles and Competitive Challenges in Drug Development
Premium
Ratings
Sell Rating for Altimmune Inc. Due to Financial Struggles and Competitive Challenges in Drug Development
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100